Date of event
Thursday, September 24, 2020 - 5:00 pm -
Thursday, September 24, 2020 - 6:00 pm
Continuing Education Credits

Content Contributors

American Association for the Study of Liver Diseases (AASLD)

Canadian Association for the Study of the Liver (CASL)

Mexican Association of Hepatology (AMH)

AASLD COVID-19 Clinical Oversight Subcommittee


Kelly W. Burak, MD, FRCPC, MSc
University of Calgary

Laura E. Cisneros Garza, MD
Hospital San José Tec Salud, Monterrey N.L.

Brett Fortune, MD, MSc
Weill Cornell Medicine, New York


Jennifer C. Price, MD, PhD
University of California, San Francisco

Jordan J. Feld, MD, MPH, FAASLD
Toronto Western Hospital Liver Center

Ignacio Aiza, MD
Hospital Angeles Lomas


The American Association for the Study of Liver Diseases, the Canadian Association for the Study of the Liver, and the Mexican Association for the Study of the Liver are joining forces to lead a timely discussion on the impact of the varied public health responses to the COVID-19 pandemic on patients with liver disease. After providing an update on the burden of COVID-19 in general and on the liver patient population throughout North America, speakers and panelists from Canada, Mexico and the United States will discuss similarities and differences in terms of access to care in the three countries and address ways in which clinicians and researchers can address health care disparities in their own practices.

This webinar will:

  • Review the burden of COVID-19 in general and within the hepatology patient population in Canada, Mexico, and the United States.
  • Compare and contrast current public health measures, guidelines, and community response throughout North America.
  • Describe the similarities and differences in access to care and related to health care disparities by region.
  • Identify possible solutions to reduce regional health care disparities related to COVID-19 in patients with liver disease.

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, September 22, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.

Presenter Bios

Kelly W. Burak, MD, FRCPC, MSc

Kelly Burak received his BSc (Biology), MD and Internal Medicine training at the University of Saskatchewan before completing training in Gastroenterology & Hepatology at the University of Calgary, and a fellowship in Hepatology & Liver Transplantation at the Mayo Clinic in Rochester, Minnesota. In 2005, Dr. Burak was awarded his MSc in Epidemiology from the University of Calgary, and in 2012 he obtained a Graduate Certificate in Clinical Education from Flinders University in Adelaide, Australia.

Dr. Burak is currently a Professor of Medicine and Oncology at the University of Calgary. He served as the Director of the Southern Alberta Liver Transplant Clinic for 19 years. Dr. Burak has more than 100 peer-reviewed publications, which include CASL clinical practice guidelines on the management of viral hepatitis and liver cancer. He has a passion for Medical Education and has won a number of teaching awards, including the 2020 CASL Education Award. Dr. Burak currently serves as the Associate Dean of Continuing Medical Education & Professional Development and the Co-Lead of the Physician Learning Program at the University of Calgary.

Photo of Kelly W. Burak, MD, FRCPC, MSc


Laura E. Cisneros Garza, MD

Dr. Cisneros completed her doctorate in medicine from the Universidad Autónoma de Nuevo León where she specialized in Hepatology. She completed Gastroenterology specialization in an academic public hospital, Unidad Medica de Alta Especialidad No 25 Instituto Mexicano del Seguro Social ( IMSS). In addition, Dr. Cisneros completed a fellowship in Digestive Endoscopy at the International Center for Digestive Endoscopy Teaching at Fujigaoka Hospital of Showa University, Yokohama, Japan, and a fellowship in Hepatology and Liver Transplantation at the Hospital Clinic de Barcelona, Spain, Institute of Digestive Diseases. She is currently a member of the Liver Transplant Committee Hospital San Jose Tec Salud and Hospital Christus Muguerza. She practices in Gastroenterology, Hepatology and Endoscopy at the Liver Disease Center of the San José Hospital in the city of Monterrey, Nuevo León. And, she is the current President of the Mexican Association for the Study of the Liver.

Photo of Laura E. Cisneros Garza, MD


Brett Fortune, MD, MSc

Brett Fortune, MD, MSc is an Associate Professor in the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and a transplant hepatologist at New York Presbyterian Hospital/Center of Liver Disease and Transplantation. Dr Fortune performs clinical research focused on the complications of cirrhosis and portal hypertension in addition to healthcare delivery for chronic liver disease and liver transplantation. He is currently the Chair of the AASLD Public Health/Healthcare Delivery Special Interest group and has participated in several consortia focused on high quality care for patients with cirrhosis, particularly among those with significant portal hypertension.

Photo of Brett Fortune, MD, MSc

Moderator Bios

Jennifer Price, MD, PhD

Jennifer Price, MD, PhD is an Associate Professor in the Department of Medicine and Division of Gastroenterology and Hepatology at the University of California, San Francisco (UCSF) and Director of the UCSF Viral Hepatitis Center. Her research examines the contributions of novel and traditional factors associated with liver disease and fibrosis progression in large observational HIV cohorts, with or without viral hepatitis. Dr. Price is a PI of the San Francisco Bay Area site of the Multicenter AIDS Cohort Study (MACS)/Women’s Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS), which integrates two of the largest and longest running NIH-funded prospective cohorts of men and women with and at risk for HIV in the U.S. She also serves as co-Chair of the MWCCS Liver Working Group and Vice Chair of the AASLD HCV SIG. Dr. Price is a member of the End Hep C SF Coordinating Committee and leads the UCSF HCV Project Extension for Community Healthcare Outcomes (ECHO), a collaborative model of medical education and care management focused on building capacity for HCV care among primary care providers throughout Northern California. She is the founding director of the DeLIVER Care Van, a mobile unit aimed at improving access to HCV screening and high-quality liver-related health care among marginalized communities.

Photo of Jennifer C. Price, MD, PhD


Jordan J. Feld, MD, MPH, FAASLD

Dr. Feld attended medical school at the University of Toronto and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Dr. Feld holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital and the Sandra Rotman Centre for Global Health at the University of Toronto. He leads a large clinical research team evaluating new therapeutics and diagnostics for hepatitis B and C virus infections and has led pivotal international trials to establish new treatment paradigms. He serves on the AASLD/IDSA hepatitis C treatment guidance panel and the Panamerican Health Organization Technical Advisory Group on Viral Hepatitis and has co-chaired international congresses including the International Symposium on Viral Hepatitis and Liver Disease, the International Viral Hepatitis Elimination Meeting and HCV2020. He founded and co-Chairs the Schwartz-Reisman Liver Research Centre that brings together all senior investigators doing basic and translational research in liver disease at the University of Toronto. His primary laboratory interests focus on understanding virological adaptations to the intrahepatic antiviral immune response.

Photo of Jordan J. Feld, MD, MPH, FAASLD


Ignacio Aiza, MD

Dr. Aiza is a board Certified Internist and Gastroenterologist. He received his MD from the Anahuac University in Mexico City. He did his postgraduate training in Internal medicine and Hepatology at Jackson Memorial Hospital in Miami and his Gastroenterology training at the University of South Florida.

His career interests include the prevention, diagnosis and treatment of chronic GI disorders with a focus in Chronic liver disease, viral hepatitis and NAFLD.

Photo of Ignacio Aiza, MD